![[Live Today] Tatva Chintan Pharma IPO: Grey Market Premium (GMP) & Kostak Rates](https://policeresults.com/img/Tatva-Chintan-Pharma-IPO-Grey-Market-Premium.jpg)
Short Info: [Live Updates] Tatva Chintan Pharma Chem Ltd IPO GMP Chanakya Details & Date: Tatva Chintan Pharma IPO Grey Market Premium Status live check at Official Website www.nseindia.com & www.bseindia.com.
Tatva Chintan Pharma IPO GMP Today: Live Updates
| Category | Details |
|---|---|
| Date & Time | On 18 July 2021 @ 12.00 noon |
| Grey Market Premium | Rs. 750/770 |
| Application Rates | Rs. 350 |
| Subject to Rates | Rs. 7300 |
Tatva Chintan Pharma IPO Grey Market Premium & Kostak Rates
Tatva Chintan Pharma Chem Ltd. is a speciality chemicals manufacturing company. It is the largest and only commercial manufacturer of structure-directing agents (SDAs) for zeolites in India.
Tatva Chintan Pharma IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹500.00 Crores. The issue is priced at ₹1073 to ₹1083 per equity share. The minimum order quantity is 13 Shares. The IPO opens on Jul 16, 2021, and closes on Jul 20, 2021. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The offer size is Rs 500 crore, of which the company will issue fresh equity shares worth Rs 225 crore and offer for sale by promoters and shareholders worth Rs 275 crore.
Investors can bid for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter. Up to 50 percent of the total offer is reserved for qualified institutional buyers, 35 percent for retail investors, and the rest 15 percent for non-institutional investors.
Tatva Chintan Pharma IPO Subscription Status [Live Updates]
Check out Tatva Chintan Pharma IPO grey market premium, Kostak rates, and subject to sauda rates as of today.
Tatva Chintan Pharma IPO Details
| Name of Article | Tatva Chintan Pharma IPO |
| IPO Date | Jul 16, 2021, to Jul 20, 2021 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Approx ₹450 Crores |
| Fresh Issue | Approx ₹225 Crores |
| Offer for Sale | Approx ₹225 Crores |
| Face Value | ₹10 per equity share |
| IPO Price | ₹1073 to ₹1083 per equity share |
| Market Lot | 13 Shares |
| Min Order Quantity | 13 Shares |
| Listing At | BSE, NSE |
Tatva Chintan Pharma IPO GMP Details (Day by Day) with Kotak rates
| Date | GMP | Kostak | Subject to |
| 19 July | |||
| 18 July | ₹ 750/770 | ₹350 | ₹7300 |
| 17 July | ₹750 | ₹450 | ₹7500 |
| 16 July | ₹690 | ₹350 | ₹7000 |
| 15 July | ₹650 | ₹300 | ₹6000 |
| 14 July | ₹570 | ₹400 | ₹5000 |
| 13 July | ₹480 | ₹350 | ₹5000 |
| 12 July | ₹570 | ₹350 | ₹5000 |
| 11 July | ₹450 | ₹350 | ₹5000 |
| 10 July | ₹450 | ₹350 | ₹5000 |
| 09 July | ₹450 | ₹350 | ₹5000 |
| 08 July | ₹0 | ₹0 | ₹0 |
| 07 July | ₹0 | ₹0 | ₹0 |
Tatva Chintan Pharma IPO Date & Price Band
The price band for the offer has been fixed at Rs 1,073-1,083 per equity share, as per the IPO advertisement published in daily newspapers today.
| IPO Open | 16 July 2021 |
| IPO Close | 20 July 2021 |
| Price Band | ₹1073 to ₹1083 Per Share |
| Listing on | BSE & NSE |
| Retail Portion | 35% |
| Equity | – Shares |
| Discount | N/A |
Tatva Chintan Pharma IPO Market Lot
| Minimum Lot Size: | Minimum 13 Shares |
| Minimum Amount: | ₹14,079 |
| Maximum Lot Size: | Maximum 182 Shares |
| Maximum Amount: | ₹197,106 |
Tatva Chintan Pharma IPO Timetable: Allotment & Listing Date
| IPO Opens On | Jul 16, 2021 |
| IPO Closes On | Jul 20, 2021 |
| Finalization of Basis of Allotment | Jul 26, 2021 |
| Initiation of Refunds | Jul 27, 2021 |
| The credit of Shares to Demat Account | Jul 28, 2021 |
| IPO Listing Date | Jul 29, 2021 |
Tatva Chintan Pharma IPO Shares Offered
| Category | Shares Offered |
|---|---|
| QIB | ( 50% ) 2308403 Shares = Rs 250 Crs |
| NII | ( 15% ) 692520 Shares = Rs 75 Crs |
| Retail | ( 35% ) 1615882 Shares = Rs 175 Crs |
| Lot size: 13 | 124298 Forms |
| Retail Min. Application | 13 Shares Rs 14079 |
| Retail Max Application | 182 Shares Rs197106 |
Tatva Chintan Pharma’s financial Performance (in INR crore)
| Financial Year Ended | Revenue (₹ Crores) | PAT (₹ Crores) | EPS (₹) |
| March 2019 | 206.80 | 20.54 | 10.23 |
| March 2020 | 264.62 | 37.79 | 18.81 |
| March 2021 | 306.29 | 52.26 | 26.02 |
FAQ of Tatva Chintan Pharma IPO:
The Tatva Chintan Pharma IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.
The Tatva Chintan Pharma IPO GMP aka grey market premium is ₹600.
The Tatva Chintan Pharma IPO kostak rate is ₹350.
The Tatva Chintan Pharma IPO subject to sauda rates is ₹7000.
The Tatva Chintan Pharma expected return is 40%.
#This is only coverage of News related to Grey Market. We donot deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.